Intellia's (NTLA) Q1 Earnings & Revenues Beat Estimates

Intellia Therapeutics, Inc. (NTLA) reported first-quarter 2024 loss of $1.06 per share, which was narrower than the Zacks Consensus Estimate of a loss of $1.35. In the year-ago quarter, Intellia incurred a loss of $1.17 per share.The reported loss excluded a one-time expense of change in fair value of investments, net, including which the company reported a loss of $1.12 per share in the first quarter of 2024.The company’s total revenues currently comprise only collaboration revenues. NTLA reported revenues ...